More tools:Markets·Screener·Research·Chat

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) Financial Statements

Orchestra BioMed Holdings, Inc. Ordinary Shares
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00W5FR3L1
XNAS · usd
5.45▲ 0.02 (0.37%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close5.43
Day's Range5.26 – 5.46
52-Week Range2.20 – 5.78
Volume198.5K
Avg Volume296.1K
Share Statistics
Shares Outstanding
Employees86
ExchangeXNAS
Listed2023-01-27
Share count as of August 6, 2026
Loading Income Statement…
Key questions about Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO)
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Market Cap?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Market Cap is $327.6M, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Enterprise Value?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Enterprise Value is $232.6M, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Price / Sales?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Price / Sales is 10.2×, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's EV / Revenue?
Orchestra BioMed Holdings, Inc. Ordinary Shares's EV / Revenue is 7.3×, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's EV / EBITDA?
Orchestra BioMed Holdings, Inc. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Revenue (TTM)?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Revenue (TTM) is $32.0M, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Net Income (TTM)?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Net Income (TTM) is -$59.0M, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's EBITDA?
Orchestra BioMed Holdings, Inc. Ordinary Shares's EBITDA is -$57.6M, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's Diluted EPS (TTM)?
Orchestra BioMed Holdings, Inc. Ordinary Shares's Diluted EPS (TTM) is -0.98, based on as-reported figures from SEC (XBRL) filings.
What is Orchestra BioMed Holdings, Inc. Ordinary Shares's EBITDA Margin?
Orchestra BioMed Holdings, Inc. Ordinary Shares's EBITDA Margin is -180.3%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth-89.9%+12120.2%-12.8%
Expenses:
Cost of product revenues
Research and development
Selling, general and administrative
Total expenses
% of revenue25504.5%78.2%2459.2%
Loss from operations
% of revenue-25404.5%21.8%-2359.2%
Other (expense) income:
Interest (expense) income, net
Change in the fair value of derivative liability——
Gain on sale of strategic investments——
Total other (expense) income
Net loss
% of revenue-26994.3%20.2%-2419.0%
Net loss attributable to common stockholders——
Net loss attributable to common stockholders per share
Basic (in dollars per share)
Diluted (in dollars per share)